CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

With an impressive 4.4-star rating and hundreds of rave reviews, I shouldn’t have been too surprised to see that this eye product worked. But, like I said, my eyes were puffy, and I could be a bit of ...

AbbVie and Eli Lilly have left the Voluntary ... has "sent a warning signal to the UK government". The two companies' products will now fall under the alternative Statutory Scheme for Branded ...